MINI FUTURE LONG - BALCHEM CO. Stock

Certificat

DE000ME18BR6

Market Closed - Börse Stuttgart 03:19:56 2024-05-28 pm EDT
6.47 EUR -1.22% Intraday chart for MINI FUTURE LONG - BALCHEM CO.
Current month+14.11%
1 month+17.21%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-28 6.47 -1.22%
24-05-27 6.55 -1.36%
24-05-24 6.64 -0.45%
24-05-23 6.67 -2.91%
24-05-22 6.87 +1.33%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 03:19 pm EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying BALCHEM CORPORATION
Issuer Morgan Stanley
WKN ME18BR
ISINDE000ME18BR6
Date issued 2023-09-27
Strike 81.64 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.68
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.26
Lowest since issue 3.44

Company Profile

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Sector
-
More about the company

Ratings for Balchem Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Balchem Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
152 USD
Average target price
166 USD
Spread / Average Target
+9.19%
Consensus